Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

1.

Fatal hepatic necrosis following imatinib mesylate therapy.

Lin NU, Sarantopoulos S, Stone JR, Galinsky I, Stone RM, Deangelo DJ, Soiffer RJ.

Blood. 2003 Nov 1;102(9):3455-6. No abstract available.

PMID:
14568907
[PubMed - indexed for MEDLINE]
Free Article
2.

Treatment of polycythemia vera with recombinant interferon alpha (rIFNalpha) or imatinib mesylate.

Silver RT.

Curr Hematol Rep. 2005 May;4(3):235-7. Review.

PMID:
15865878
[PubMed - indexed for MEDLINE]
3.

Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia.

Kong JH, Yoo SH, Lee KE, Nam SH, Kwon JM, Lee SM, Chang HJ, Choi MY, Cho MS, Mun YC, Nam E, Lee SN, Seong CM.

Acta Haematol. 2007;118(4):205-8. Epub 2007 Nov 15.

PMID:
18030002
[PubMed - indexed for MEDLINE]
4.

Severe hepatic injury caused by imatinib mesylate administered for the treatment of chronic myeloid leukemia and the efficacy of prednisolone for its management.

Ikuta K, Torimoto Y, Jimbo J, Inamura J, Shindo M, Sato K, Tokusashi Y, Miyokawa N, Kohgo Y.

Int J Hematol. 2005 Nov;82(4):343-6.

PMID:
16298828
[PubMed - indexed for MEDLINE]
5.

[Imatinib mesylate-induced acute cytolytic hepatitis].

Rocca P, El Jastimi S, Troncy J, Scoazec JY, Boucher A, Vial T, Trépo C, Zoulim F.

Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):918-9. French. No abstract available.

PMID:
15523233
[PubMed - indexed for MEDLINE]
Free Article
6.

Massive bone marrow necrosis in a patient with chronic myelocytic leukemia following imatinib mesylate therapy.

Tamura T, Tasaka T, Fujimoto M, Matsuhashi Y, Fukumot T, Mano S, Kuwajima M, Nagai M.

Haematologica. 2004 Sep;89(9):ECR32. No abstract available.

PMID:
15377484
[PubMed - indexed for MEDLINE]
Free Article
7.

Polycythemia vera responds to imatinib mesylate.

Jones CM, Dickinson TM.

Am J Med Sci. 2003 Mar;325(3):149-52.

PMID:
12640290
[PubMed - indexed for MEDLINE]
8.

Phase II open label trial of imatinib in polycythemia rubra vera.

Jones CM, Dickinson TM, Salvado A.

Int J Hematol. 2008 Dec;88(5):489-94. doi: 10.1007/s12185-008-0193-1. Epub 2008 Nov 15.

PMID:
19009241
[PubMed - indexed for MEDLINE]
9.

Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase.

Yamazaki R, Okamoto S, Chen CK, Tada S, Saito H, Shibata R, Sakamoto M, Mori T, Ikeda Y.

Leuk Lymphoma. 2006 Jul;47(7):1427-30. No abstract available.

PMID:
16923586
[PubMed - indexed for MEDLINE]
10.

Imatinib mesylate as a cause of acute liver failure.

Cross TJ, Bagot C, Portmann B, Wendon J, Gillett D.

Am J Hematol. 2006 Mar;81(3):189-92.

PMID:
16493605
[PubMed - indexed for MEDLINE]
11.

Imatinib-induced fatal acute liver failure.

Ridruejo E, Cacchione R, Villamil AG, Marciano S, Gadano AC, Mandó OG.

World J Gastroenterol. 2007 Dec 28;13(48):6608-111.

PMID:
18161937
[PubMed - indexed for MEDLINE]
Free Article
12.

Update on the treatment of polycythemia vera with recombinant interferon alfa or imatinib mesylate.

Silver RT.

Curr Hematol Malig Rep. 2007 Feb;2(1):43-6. doi: 10.1007/s11899-007-0006-2. Review.

PMID:
20425387
[PubMed - indexed for MEDLINE]
13.

Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment.

Ikeda K, Shiga Y, Takahashi A, Kai T, Kimura H, Takeyama K, Noji H, Ogawa K, Nakamura A, Ohira H, Sato Y, Maruyama Y.

Leuk Lymphoma. 2006 Jan;47(1):155-7.

PMID:
16321842
[PubMed - indexed for MEDLINE]
14.

Imatinib mesylate (Gleevec(TM)) reduces phlebotomy requirements in polycythemia vera.

Silver RT.

Leukemia. 2003 Jun;17(6):1186-7. No abstract available.

PMID:
12764388
[PubMed - indexed for MEDLINE]
15.

Long term follow-up of Polycythemia Vera patients treated with imatinib mesylate.

Michael Jones C.

Leuk Res. 2012 Jul;36(7):815-6. doi: 10.1016/j.leukres.2012.03.011. Epub 2012 Apr 5. No abstract available.

PMID:
22483066
[PubMed - indexed for MEDLINE]
16.

Imatinib mesylate-induced acute hepatitis in a patient treated for gastrointestinal stromal tumour.

Pariente A, Etcharry F, Cales V, Laborde Y, Ferrari S, Biour M.

Eur J Gastroenterol Hepatol. 2006 Jul;18(7):785-7. Review.

PMID:
16772838
[PubMed - indexed for MEDLINE]
17.

Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection.

Thia TJ, Tan HH, Chuah TH, Chow WC, Lui HF.

Singapore Med J. 2008 Mar;49(3):e86-9.

PMID:
18362995
[PubMed - indexed for MEDLINE]
Free Article
18.

Listeria monocytogenes meningitis following imatinib mesylate-induced monocytopenia in a patient with chronic myeloid leukemia.

Ferrand H, Tamburini J, Mouly S, Bouscary D, Bergmann JF.

Clin Infect Dis. 2005 Dec 1;41(11):1684-5. No abstract available.

PMID:
16267747
[PubMed - indexed for MEDLINE]
Free Article
19.

Treatment of polycythemia vera with imatinib mesylate.

Silver RT, Bourla MH, Vandris K, Fruchtman S, Spivak JL, Feldman EJ, Salvado AJ.

Leuk Res. 2012 Feb;36(2):156-62. doi: 10.1016/j.leukres.2011.09.001. Epub 2011 Oct 7.

PMID:
21983176
[PubMed - indexed for MEDLINE]
20.

Multiple brain infarctions induced by imatinib mesylate in a patient with clonal eosinophilia.

Sato E, Sugimoto K, Hamano Y, Isobe Y, Sasaki M, Tomomatsu J, Nitta H, Oshimi K.

Int J Hematol. 2008 May;87(4):444-5. doi: 10.1007/s12185-008-0074-7. No abstract available.

PMID:
18409077
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk